Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukaemia, Myelocytic, Acute”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Early research (Phase 1)Study completedNCT00125840
What this trial is testing

Clofarabine in Adult Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsLeukemia, Lymphocytic, Acute, PediatricLeukemia, Lymphocytic, Acute, Adult+3 more
Genzyme, a Sanofi Company
Not applicableUnknownNCT00449319
What this trial is testing

AML Treatment in Untreated Adult Patients

Who this might be right for
Leukemia, Myelocytic, Acute
Gruppo Italiano Malattie EMatologiche dell'Adulto
Early research (Phase 1)UnknownNCT02895412
What this trial is testing

Infection and Tumour Antigen Cellular Therapy

Who this might be right for
Leukemia, Myelocytic, Acute
University of Sydney 20
Testing effectiveness (Phase 2)Study completedNCT01716793
What this trial is testing

Risk-adapted Therapy for Adult Acute Myeloid Leukemia.

Who this might be right for
Leukemia, Myelocytic, Acute
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias 354
Testing effectiveness (Phase 2)Ended earlyNCT01621477
What this trial is testing

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelocytic LeukemiaChronic Myelocytic Leukemia+4 more
St. Jude Children's Research Hospital 34
Early research (Phase 1)Study completedNCT01607892
What this trial is testing

Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

Who this might be right for
Hematological Malignancies
Karyopharm Therapeutics Inc 286
Early research (Phase 1)Ended earlyNCT02177812
What this trial is testing

A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML)

Who this might be right for
Leukaemia, Myelocytic, Acute
GlaxoSmithKline 41
Early research (Phase 1)Ended earlyNCT00048100
What this trial is testing

Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes

Who this might be right for
Leukemia, Myelocytic, Acute
M.D. Anderson Cancer Center 2
Early research (Phase 1)UnknownNCT03796390
What this trial is testing

Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocytic Leukemia

Who this might be right for
Acute Myelocytic Leukemia
Hebei Senlang Biotechnology Inc., Ltd. 15
Not applicableStudy completedNCT00286845
What this trial is testing

Use of the MiCK Assay for Apoptosis in AML

Who this might be right for
Leukemia, Myelocytic, Acute
Pierian Biosciences 50
Large-scale testing (Phase 3)Ended earlyNCT00152594
What this trial is testing

Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia

Who this might be right for
Leukemia, Myelocytic, Acute
University of Cologne 150
Early research (Phase 1)Study completedNCT00725283
What this trial is testing

Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Leukaemia, Myelocytic, Acute
GlaxoSmithKline 34
Early research (Phase 1)Study completedNCT00251368
What this trial is testing

Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia

Who this might be right for
Leukemia, Myelocytic, AcuteAcute Lymphocytic Leukemia
Dana-Farber Cancer Institute 52
Post-approval studies (Phase 4)Study completedNCT00304447
What this trial is testing

Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia

Who this might be right for
Leukemia, Myelocytic, AcuteInfusions, Intravenous
Wyeth is now a wholly owned subsidiary of Pfizer 30
Post-approval studies (Phase 4)Study completedNCT01735955
What this trial is testing

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

Who this might be right for
Chronic Myelogenous Leukemia (CML)Metastatic Gastrointestinal Stromal Tumors (GIST)Acute Lymphoblastic Leukemia (ALL)+1 more
Novartis Pharmaceuticals 57
Not applicableUnknownNCT00155844
What this trial is testing

Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier"

Who this might be right for
Acute Myelocytic LeukemiaAcute Lymphocytic Leukemia
National Taiwan University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00067002
What this trial is testing

Randomized Double Cord Blood Transplant Study

Who this might be right for
Leukemia, Lymphocytic, AcuteLeukemia, Myelocytic, AcuteLeukemia, Myeloid, Chronic+1 more
M.D. Anderson Cancer Center 110
Early research (Phase 1)Study completedNCT01051063
What this trial is testing

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Who this might be right for
Leukaemia, Myelocytic, Acute
GlaxoSmithKline 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07423104
What this trial is testing

Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
University of Rochester 24
Early research (Phase 1)Study completedNCT00479232
What this trial is testing

Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1)

Who this might be right for
Leukemia, Myelocytic, Acute Myelodysplastic SyndromesMyelodysplastic Syndromes
Merck Sharp & Dohme LLC 71
Load More Results